Plante Moran Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Buy
2,109
+17
+0.8% +$5.82K 0.04% 69
2026
Q1
$736K Sell
2,092
-14
-0.7% -$4.99K 0.05% 61
2025
Q4
$689K Buy
2,106
+14
+0.7% +$4.44K 0.04% 72
2025
Q3
$590K Buy
2,092
+1
+0% +$290 0.04% 75
2025
Q2
$584K Sell
2,091
-60
-3% -$17K 0.04% 73
2025
Q1
$670K Sell
2,151
-5,093
-70% -$1.5M 0.06% 65
2024
Q4
$1.89M Sell
7,244
-17
-0.2% -$5.04K 0.16% 30
2024
Q3
$2.34M Buy
7,261
+17
+0.2% +$5.56K 0.2% 27
2024
Q2
$2.26M Sell
7,244
-14
-0.2% -$4.11K 0.23% 27
2024
Q1
$2.06M Sell
7,258
-234
-3% -$68.5K 0.22% 30
2023
Q4
$2.16M Buy
7,492
+5,251
+234% +$1.43M 0.23% 28
2023
Q3
$602K Hold
2,241
0.07% 64
2023
Q2
$498K Sell
2,241
-7
-0.3% -$1.62K 0.06% 84
2023
Q1
$543K Buy
2,248
+123
+6% +$30.2K 0.07% 79
2022
Q4
$558K Buy
2,125
+47
+2% +$12.6K 0.08% 76
2022
Q3
$468K Sell
2,078
-96
-4% -$23.3K 0.08% 80
2022
Q2
$529K Sell
2,174
-139
-6% -$34.1K 0.09% 75
2022
Q1
$559K Sell
2,313
-40
-2% -$9.19K 0.1% 77
2021
Q4
$529K Sell
2,353
-699
-23% -$148K 0.09% 83
2021
Q3
$649K Buy
3,052
+781
+34% +$180K 0.14% 69
2021
Q2
$554K Sell
2,271
-72
-3% -$17.7K 0.13% 75
2021
Q1
$583K Buy
2,343
+210
+10% +$50.1K 0.16% 72
2020
Q4
$490K Sell
2,133
-598
-22% -$138K 0.15% 81
2020
Q3
$694K Hold
2,731
0.24% 57
2020
Q2
$644K Sell
2,731
-61
-2% -$13.9K 0.26% 54
2020
Q1
$566K Buy
2,792
+111
+4% +$24.2K 0.26% 56
2019
Q4
$646K Sell
2,681
-380
-12% -$83.8K 0.22% 63
2019
Q3
$592K Buy
3,061
+13
+0.4% +$2.5K 0.17% 77
2019
Q2
$562K Sell
3,048
-3,584
-54% -$642K 0.17% 76
2019
Q1
$1.26M Sell
6,632
-322
-5% -$61.5K 0.39% 38
2018
Q4
$1.35M Buy
6,954
+1,329
+24% +$259K 0.47% 31
2018
Q3
$1.17M Buy
5,625
+3,259
+138% +$642K 0.38% 35
2018
Q2
$437K Buy
2,366
+543
+30% +$96K 0.22% 81
2018
Q1
$311K Buy
1,823
+506
+38% +$92.9K 0.17% 109
2017
Q4
$229K Buy
1,317
+770
+141% +$136K 0.13% 122
2017
Q3
$102K Hold
547
0.06% 201
2017
Q2
$94K Sell
547
-31
-5% -$5.04K 0.06% 207
2017
Q1
$95K Sell
578
-2,547
-82% -$423K 0.06% 210
2016
Q4
$457K Buy
3,125
+2,790
+833% +$420K 0.29% 71
2016
Q3
$56K Hold
335
0.04% 290
2016
Q2
$51K Sell
335
-23
-6% -$3.58K 0.04% 277
2016
Q1
$54K Sell
358
-231
-39% -$34.3K 0.04% 251
2015
Q4
$96K Sell
589
-39
-6% -$6.13K 0.07% 192
2015
Q3
$87K Sell
628
-164
-21% -$25.9K 0.07% 196
2015
Q2
$122K Buy
792
+324
+69% +$51.9K 0.09% 168
2015
Q1
$75K Hold
468
0.05% 225
2014
Q4
$75K Hold
468
0.06% 219
2014
Q3
$66K Sell
468
-255
-35% -$33.3K 0.06% 214
2014
Q2
$86K Buy
723
+489
+209% +$56.6K 0.08% 163
2014
Q1
$29K Sell
234
-77
-25% -$9.34K 0.03% 214
2013
Q4
$35K Buy
311
+79
+34% +$8.99K 0.02% 283
2013
Q3
$26K Buy
232
+209
+909% +$22.7K 0.02% 256
2013
Q2
$2K Buy
+23
New +$2.39K ﹤0.01% 529

Other funds holding AMGN

Plante Moran Financial Advisors's AMGN Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its Amgen (AMGN) stake by 0.81% in Q2 2026, buying an estimated $5.82K and bringing the position to 2,109 shares worth $764K. The position accounts for 0.04% of the portfolio, ranked #69.

Plante Moran Financial Advisors first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.34M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Plante Moran Financial Advisors held 2,109 shares of Amgen worth $764K as of Q2 2026.
  • Plante Moran Financial Advisors bought 17 Amgen shares in Q2 2026, an estimated $5.82K.
  • Amgen made up 0.04% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #69 holding.
  • Plante Moran Financial Advisors first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Plante Moran Financial Advisors's Amgen position peaked at $2.34M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.